Cinven's indicative EUR 10 per share Synlab bid seen as below fair value

Cinven’s non-binding expression of interest for German laboratory diagnostic services provider Synlab at EUR 10 per share, announced on 13 March, is considered below fair value, two minority shareholders told Unquote sister publication Mergermarket.